MedPath

SYRACUSE UNIVERSITY

SYRACUSE UNIVERSITY logo
🇦🇪United Arab Emirates
Ownership
Private
Established
1870-03-24
Employees
1K
Market Cap
-
Website
http://www.syracuse.edu

Clinical Trials

30

Active:3
Completed:19

Trial Phases

3 Phases

Phase 1:4
Phase 2:4
Not Applicable:21

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (29 trials with phase data)• Click on a phase to view related trials

Not Applicable
21 (72.4%)
Phase 1
4 (13.8%)
Phase 2
4 (13.8%)

Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production

Not Applicable
Recruiting
Conditions
Speech Sound Disorder
First Posted Date
2025-07-11
Last Posted Date
2025-07-11
Lead Sponsor
Syracuse University
Target Recruit Count
120
Registration Number
NCT07061730
Locations
🇺🇸

Syracuse University, Syracuse, New York, United States

A Digital Resilience Intervention for Emergency Medical Service Workers

Not Applicable
Completed
Conditions
Feasibility
Acceptability
Adoptability
Meaning Made
Adaptive Self-reflection
Recovery Activities
Recovery Experiences
Post Traumatic Stress Disorder PTSD
Anxiety
Depression
First Posted Date
2025-03-06
Last Posted Date
2025-03-10
Lead Sponsor
Syracuse University
Target Recruit Count
83
Registration Number
NCT06861400
Locations
🇺🇸

Syracuse University, Syracuse, New York, United States

Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance

Not Applicable
Active, not recruiting
Conditions
Vaccine Uptake
First Posted Date
2024-11-21
Last Posted Date
2024-11-21
Lead Sponsor
Syracuse University
Target Recruit Count
40
Registration Number
NCT06698497
Locations
🇺🇸

Syracuse University, Syracuse, New York, United States

Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers

Not Applicable
Recruiting
Conditions
HIV-1-infection
Alcohol Drinking
First Posted Date
2024-10-18
Last Posted Date
2025-01-27
Lead Sponsor
Syracuse University
Target Recruit Count
300
Registration Number
NCT06648629
Locations
🇺🇸

Syracuse University, Syracuse, New York, United States

AI-Assisted Treatment for Residual Speech Sound Disorders

Not Applicable
Recruiting
Conditions
Speech Sound Disorder
First Posted Date
2023-08-14
Last Posted Date
2025-01-27
Lead Sponsor
Syracuse University
Target Recruit Count
26
Registration Number
NCT05988515
Locations
🇺🇸

Syracuse University, Syracuse, New York, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

Novel Peptide Compounds Show Promise as Ozempic Alternatives with Reduced GI Side Effects

Researchers have developed two new peptide compounds, GEP44 and KCEM1, that target weight loss with potentially fewer gastrointestinal side effects than current GLP-1 drugs.

© Copyright 2025. All Rights Reserved by MedPath